Home > Healthcare > Medical Devices > Diagnostic Devices > Helicobacter Pylori Testing Market

Helicobacter Pylori Testing Market Size

  • Report ID: GMI4408
  • Published Date: Nov 2022
  • Report Format: PDF

Helicobacter Pylori Testing Market Size

Helicobacter Pylori Testing Market size was valued at over USD 447 million in 2022. Driven by the increasing instances of peptic ulcers, the market is slated to register over 6.5% CAGR from 2023 to 2032.

 

People infected with helicobacter pylori are prone to gastric ulcers as the bacteria can damage the inner protective lining of their intestine as well as stomach. Based on that co-relation, growing cases of gastric ulcers across the globe are primarily fueling the demand for helicobacter pylori testing.

 

Lack of trained physicians for invasive testing may constrain industry development

Helicobacter pylori infection is typically diagnosed through an invasive procedure, which entails biopsy and endoscopy, and requires advanced operational skills for precisely diagnosing and identifying the appropriate treatment method. However, the lack of trained professionals in nations with limited healthcare resources may affect the disease testing rates, dampening the market progress. Many low and middle-income economies lack the hospital and medical training infrastructure needed to highly skilled physicians. Helicobacter pylori treatment also poses other challenges for physicians as no first-line therapy can treat the infection for all patients.
 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for helicobacter pylori testing held a valuation of over USD 447 million and is slated to grow at over 6.5% CAGR between 2023 and 2032.

Invasive test segment is anticipated to grow at 6.5% CAGR from 2023 to 2032, driven by the efficacy and affordability of rapid urease tests, and increasing demand from patients who do not correspond well to antibiotic therapy.

APAC helicobacter pylori testing market is poised to grow at over 8.5% CAGR from 2023 to 2032, driven by increasing instances of infectious diseases, a rapidly growing aging population, poor sanitation practices, and healthcare infrastructure in the region.

Some of the leading market contenders include Biohit Oyj, Avanos Corporate, Bio-Rad Laboratories, bioMerieux SA, Gulf Coast Scientific, Cardinal Health, Inc., Medline Industries, among others.

Helicobacter Pylori Testing Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 337
  • Countries covered: 22
  • Pages: 204
 Download Free Sample